New $2 billion AstraZeneca deal targets 23% of all cancer types
Jacobio Pharma announced on Sunday that it granted AstraZeneca exclusive global development and commercialization rights to its experimental pan-KRAS inhibitor ...
Tag: astrazeneca
LATEST